Skip to main content
Erschienen in:

18.05.2019 | Original article

E-cadherin and periostin in early detection and progression of diabetic nephropathy: epithelial-to-mesenchymal transition

verfasst von: Nada M. Qamar El-Dawla, Al-Aliaa M. Sallam, Mohamed H. El-Hefnawy, Hala O. El-Mesallamy

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Diabetic nephropathy (DN) is a severe complication of diabetes mellitus (DM). Many mechanisms are involved in its development; one of these mechanisms is epithelial-to-mesenchymal transition (EMT). During EMT, losing of the epithelial biomarkers like E-cadherin and increasing of mesenchymal biomarkers like periostin are very characteristic.

Methods

The study included 19 healthy controls and 71 DN patients categorized according to their urinary albumin-to-creatinine ratio (UACR) into 19 normoalbuminuric (UACR < 30 mg/g), 37 microalbuminuric (UACR 30–300 mg/g), and 15 macroalbuminuric (UACR > 300 mg/g) patients. Fasting plasma glucose (FPG), glycated hemoglobin (HbA1C%), serum creatinine (Cr), and urea were measured. E-cadherin and periostin were measured by ELISA and compared among groups.

Results

Concerning E-cadherin levels, in comparison to control group, there were significantly decreased in all groups (0.94, 0.52, and 0.14 ng/mL in normoalbuminuria, microalbuminuria, and macroalbuminuria groups; respectively). For periostin levels, nonsignificant increase in normoalbuminuria (0.32 ng/mL) than control group (0.3 ng/mL) was observed. There was a significant increase in other groups with the highest values in macroalbuminuria group (1.66 ng/mL). E-cadherin and periostin were correlated with each other (r = − 0.353, P < 0.001). UACR was negatively correlated with E-cadherin and positively correlated with periostin. ROC curve analyses showed that the AUC to diagnose established microalbuminuria using E-cadherin was 0.998 (95% CI 0. 932–1), and using periostin was 0.833 (95% CI 0.709–0.919).

Conclusion

Serum E-cadherin and periostin could be considered as reliable biomarkers involved in DN pathogenesis and linked to its stages.
Literatur
1.
Zurück zum Zitat Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol. 2011;8:228–36.CrossRefPubMed Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol. 2011;8:228–36.CrossRefPubMed
2.
Zurück zum Zitat Gaballa MR, Farag YMK. Predictors of diabetic nephropathy. Cent Eur J Med. 2013;8:287–96. Gaballa MR, Farag YMK. Predictors of diabetic nephropathy. Cent Eur J Med. 2013;8:287–96.
4.
Zurück zum Zitat Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6:1246–58.CrossRefPubMedCentralPubMed Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6:1246–58.CrossRefPubMedCentralPubMed
5.
9.
Zurück zum Zitat Maître J-L, Heisenberg C. Three functions of cadherins in cell adhesion. Curr Biol. 2013;23:626–33.CrossRef Maître J-L, Heisenberg C. Three functions of cadherins in cell adhesion. Curr Biol. 2013;23:626–33.CrossRef
10.
Zurück zum Zitat Stephenson RO, Yamanaka Y, Rossant J. Disorganized epithelial polarity and excess trophectoderm cell fate in preimplantation embryos lacking E-cadherin. Dev Stem Cells. 2010;137:3383–91. Stephenson RO, Yamanaka Y, Rossant J. Disorganized epithelial polarity and excess trophectoderm cell fate in preimplantation embryos lacking E-cadherin. Dev Stem Cells. 2010;137:3383–91.
11.
Zurück zum Zitat Chijimatsu R, Kunugiza Y, Taniyama Y, Nakamura N, Tomita T. Expression and pathological effects of periostin in human osteoarthritis cartilage. BMC Musculoskelet Disord. 2015;16:1–12.CrossRef Chijimatsu R, Kunugiza Y, Taniyama Y, Nakamura N, Tomita T. Expression and pathological effects of periostin in human osteoarthritis cartilage. BMC Musculoskelet Disord. 2015;16:1–12.CrossRef
12.
Zurück zum Zitat Takada M, Ban Y, Yamamoto G, Ueda T, Saito Y, Nishimura E. Periostin, discovered by nano-flow liquid chromatography and mass spectrometry, is a novel marker of diabetic retinopathy. Biochem Biophys Res Commun. 2010;399:221–6.CrossRefPubMed Takada M, Ban Y, Yamamoto G, Ueda T, Saito Y, Nishimura E. Periostin, discovered by nano-flow liquid chromatography and mass spectrometry, is a novel marker of diabetic retinopathy. Biochem Biophys Res Commun. 2010;399:221–6.CrossRefPubMed
13.
Zurück zum Zitat Satirapoj B, Wang Y, Chamberlin MP, et al. Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells. Nephrol Dial Transplant. 2012;27:2702–11.CrossRefPubMed Satirapoj B, Wang Y, Chamberlin MP, et al. Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells. Nephrol Dial Transplant. 2012;27:2702–11.CrossRefPubMed
14.
Zurück zum Zitat Satirapoj B, Tassanasorn S, Charoenpitakchai M, Supasyndh O. Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus. PLoS One. 2015;10:e0124055.CrossRefPubMedCentralPubMed Satirapoj B, Tassanasorn S, Charoenpitakchai M, Supasyndh O. Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus. PLoS One. 2015;10:e0124055.CrossRefPubMedCentralPubMed
16.
Zurück zum Zitat Zyłka A, Gala-Błądzińska A, Dumnicka P, et al. Is urinary NGAL determination useful for monitoring kidney function and assessment of cardiovascular disease? A 12-month observation of patients with type 2 diabetes. Dis Mark. 2016;2016:8. Zyłka A, Gala-Błądzińska A, Dumnicka P, et al. Is urinary NGAL determination useful for monitoring kidney function and assessment of cardiovascular disease? A 12-month observation of patients with type 2 diabetes. Dis Mark. 2016;2016:8.
17.
Zurück zum Zitat de Carvalho JAM, Tatsch E, Hausen BS, et al. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes. Clin Biochem. 2016;49:232–6.CrossRefPubMed de Carvalho JAM, Tatsch E, Hausen BS, et al. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes. Clin Biochem. 2016;49:232–6.CrossRefPubMed
18.
Zurück zum Zitat Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol. 2010;21:212–22.CrossRefPubMed Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol. 2010;21:212–22.CrossRefPubMed
19.
Zurück zum Zitat He J, Xu Y, Koya D, Kanasaki K. Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease. Clin Exp Nephrol. 2013;17:488–97.CrossRefPubMed He J, Xu Y, Koya D, Kanasaki K. Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease. Clin Exp Nephrol. 2013;17:488–97.CrossRefPubMed
20.
Zurück zum Zitat Flier SN, Tanjore H, Kokkotou EG, Sugimoto H, Zeisberg M, Kalluri R. Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. J Biol Chem. 2010;285:20202–12.CrossRefPubMedCentralPubMed Flier SN, Tanjore H, Kokkotou EG, Sugimoto H, Zeisberg M, Kalluri R. Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. J Biol Chem. 2010;285:20202–12.CrossRefPubMedCentralPubMed
21.
Zurück zum Zitat Rizvi MR, Rukban M. E-cadherin-A surrogate marker and its relation to other biomarkers in early stages of diabetic nephropathy in eastern proving of Saudi Arabian population. J Glob Pharma Technol. 2016;8:18–26. Rizvi MR, Rukban M. E-cadherin-A surrogate marker and its relation to other biomarkers in early stages of diabetic nephropathy in eastern proving of Saudi Arabian population. J Glob Pharma Technol. 2016;8:18–26.
22.
Zurück zum Zitat Chen H, Xu Y, Yang Y, Zhou X, Dai S, Li C. Shenqiwan ameliorates renal fibrosis in rats by inhibiting TGF-β 1/smads signaling pathway. Evidence Based Complement Altern Med. 2017;2017:9. Chen H, Xu Y, Yang Y, Zhou X, Dai S, Li C. Shenqiwan ameliorates renal fibrosis in rats by inhibiting TGF-β 1/smads signaling pathway. Evidence Based Complement Altern Med. 2017;2017:9.
23.
Zurück zum Zitat Jiang H, Guan G, Zhang R, Liu G, Cheng J, Hou X, Cui Y. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy. Diabetes Metab Res Rev. 2009;25:232–41.CrossRefPubMed Jiang H, Guan G, Zhang R, Liu G, Cheng J, Hou X, Cui Y. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy. Diabetes Metab Res Rev. 2009;25:232–41.CrossRefPubMed
25.
Zurück zum Zitat Bush KT, Tsukamoto T, Nigam SK. Selective degradation of E-cadherin and dissolution of E-cadherin-catenin complexes in epithelial ischemia. Am J Physiol Renal Physiol. 2000;278:847–52.CrossRef Bush KT, Tsukamoto T, Nigam SK. Selective degradation of E-cadherin and dissolution of E-cadherin-catenin complexes in epithelial ischemia. Am J Physiol Renal Physiol. 2000;278:847–52.CrossRef
26.
Zurück zum Zitat Burns WC, Twigg SM, Forbes JM, et al. Connective tissue growth factor plays an important role in advanced glycation end product—induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol. 2006;17:2484–94.CrossRefPubMed Burns WC, Twigg SM, Forbes JM, et al. Connective tissue growth factor plays an important role in advanced glycation end product—induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol. 2006;17:2484–94.CrossRefPubMed
27.
Zurück zum Zitat Li JH, Wang W, Huang XR, Oldfield M, Schmidt AM, Cooper ME, Lan HY. Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway. Am J Pathol. 2004;164:1389–97.CrossRefPubMedCentralPubMed Li JH, Wang W, Huang XR, Oldfield M, Schmidt AM, Cooper ME, Lan HY. Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway. Am J Pathol. 2004;164:1389–97.CrossRefPubMedCentralPubMed
28.
Zurück zum Zitat Ding Y, Ge Q, Qu H, et al. Increased serum periostin concentrations are associated with the presence of diabetic retinopathy in patients with type 2 diabetes mellitus. J Endocrinol Invest. 2018;41:937–45.CrossRefPubMed Ding Y, Ge Q, Qu H, et al. Increased serum periostin concentrations are associated with the presence of diabetic retinopathy in patients with type 2 diabetes mellitus. J Endocrinol Invest. 2018;41:937–45.CrossRefPubMed
29.
Zurück zum Zitat Sen K, Lindenmeyer MT, Gaspert A, et al. Periostin is induced in glomerular injury and expressed de novo in interstitial renal fibrosis. Am J Pathol. 2011;179:1756–67.CrossRefPubMedCentralPubMed Sen K, Lindenmeyer MT, Gaspert A, et al. Periostin is induced in glomerular injury and expressed de novo in interstitial renal fibrosis. Am J Pathol. 2011;179:1756–67.CrossRefPubMedCentralPubMed
30.
Zurück zum Zitat Gordon ED, Sidhu SS, Wang ZE, et al. A protective role for periostin and TGF-β in IgE-mediated allergy and airway hyperresponsiveness. Clin Exp Allergy. 2012;42:144–55.CrossRefPubMed Gordon ED, Sidhu SS, Wang ZE, et al. A protective role for periostin and TGF-β in IgE-mediated allergy and airway hyperresponsiveness. Clin Exp Allergy. 2012;42:144–55.CrossRefPubMed
31.
Zurück zum Zitat Mael-Ainin M, Abed A, Conway SJ, Dussaule J-C, Chatziantoniou C. Inhibition of periostin expression protects against the development of renal inflammation and fibrosis. J Am Soc Nephrol. 2014;25:1724–36.CrossRefPubMedCentralPubMed Mael-Ainin M, Abed A, Conway SJ, Dussaule J-C, Chatziantoniou C. Inhibition of periostin expression protects against the development of renal inflammation and fibrosis. J Am Soc Nephrol. 2014;25:1724–36.CrossRefPubMedCentralPubMed
32.
Zurück zum Zitat Um JE, Park JT, Nam BY, et al. Periostin-binding DNA aptamer treatment attenuates renal fibrosis under diabetic conditions. Sci Rep. 2017;7:1–12.CrossRef Um JE, Park JT, Nam BY, et al. Periostin-binding DNA aptamer treatment attenuates renal fibrosis under diabetic conditions. Sci Rep. 2017;7:1–12.CrossRef
33.
Zurück zum Zitat Guerrot D, Dussaule JC, Mael-Ainin M, Xu-Dubois YC, Rondeau E, Chatziantoniou C, et al. Identification of periostin as a critical marker of progression/reversal of hypertensive nephropathy. PLoS One. 2012;7:e31974.CrossRefPubMedCentralPubMed Guerrot D, Dussaule JC, Mael-Ainin M, Xu-Dubois YC, Rondeau E, Chatziantoniou C, et al. Identification of periostin as a critical marker of progression/reversal of hypertensive nephropathy. PLoS One. 2012;7:e31974.CrossRefPubMedCentralPubMed
34.
Zurück zum Zitat Satirapoj B, Witoon R, Ruangkanchanasetr P, Wantanasiri P, Charoenpitakchai M, Choovichian P. Urine periostin as a biomarker of renal injury in chronic allograft nephropathy. Transplant Proc. 2014;46:135–40.CrossRefPubMed Satirapoj B, Witoon R, Ruangkanchanasetr P, Wantanasiri P, Charoenpitakchai M, Choovichian P. Urine periostin as a biomarker of renal injury in chronic allograft nephropathy. Transplant Proc. 2014;46:135–40.CrossRefPubMed
Metadaten
Titel
E-cadherin and periostin in early detection and progression of diabetic nephropathy: epithelial-to-mesenchymal transition
verfasst von
Nada M. Qamar El-Dawla
Al-Aliaa M. Sallam
Mohamed H. El-Hefnawy
Hala O. El-Mesallamy
Publikationsdatum
18.05.2019
Verlag
Springer Singapore
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 8/2019
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-019-01744-3

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Körperlich fitte Krebskranke leben länger

Krebspatienten, auch und vor allem solche in fortgeschrittenen Stadien, profitieren offenbar von guter körperlicher Verfassung. Hohe Muskelkraft und kardiorespiratorische Fitness sind laut Ergebnissen einer Metaanalyse mit geringerer Mortalität assoziiert.

Vorhofflimmern: Antikoagulation vor Schlaganfall von Vorteil

Erleiden Menschen mit Vorhofflimmern einen ischämischen Schlaganfall, ist dieser weniger schwer, auch sind Infarktgröße und Blutungsrisiko geringer, wenn sie zuvor orale Antikoagulanzien erhalten haben. Die Art der Antikoagulation spielt dabei keine Rolle.

HCL-Systeme bei Typ-1-Diabetes: Blutzuckerkontrolle besser, Risiko für Ketoazidose aber höher

Eine bessere Blutzuckerkontrolle und weniger Fälle von hypoglykämischem Koma, dafür mehr diabetische Ketoazidosen. Dieses HCL-Insulin-Therapie-Profil zeigte sich in einem Vergleich von Hybrid-Closed-Loop(HCL)- und Open-Loop-Systemen bei Typ-I-Diabetes im DPV-Register.

Kein (großer) Schutz vor Kolorektalkarzinom-Rezidiven durch ASS

Die erste Phase-3-Studie zum Nutzen von ASS in der adjuvanten Therapie des kolorektalen Karzinoms ist negativ verlaufen. Das abschließende Urteil über eine Sekundärprävention mit ASS ist trotzdem noch nicht gefallen.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.